Psyence BioMed Announces Approval for Use of PsyLabs Psilocybin Product in Phase IIb Clinical Trial
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq:…
TransAlta Provides Notice to Mothball Sheerness Unit 1
December 18, 2025 17:22 ET Â | Source: TransAlta Corporation CALGARY, Alberta, Dec.…
Casio India partners with NGO SHEOWS to launch ‘Every Second Counts’ CSR initiative to support homeless elderly
NEW DELHI, Dec. 17, 2025 /PRNewswire/ -- Casio India Co. Pvt. Ltd.,…
Samsung Expands Premium Micro RGB Lineup for 2026 with New Sizes and Advanced Features
From 115-inch cinematic displays to 55-inch premium formats, the new lineup offers…
Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods
BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian…
OMRON Healthcare Unveils Global ECG Strategy
New services and strategic partnerships advance Going for ZERO visionTOKYO, Dec. 11,…
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
December 09, 2025 21:50 ET Â | Source: Wave Life Sciences USA, Inc.…
Ashika Investment Managers launches Ashika Mid & Small Cap Fund, an open-ended Category III AIF
MUMBAI, India, Dec. 9, 2025 /PRNewswire/ -- Ashika Investment Managers Pvt. Ltd.…
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2025 08:00 ET Â | Source: UroGen Pharma Ltd. PRINCETON, N.J.,…